Yash Kapoor

8PUBLICATIONS
23CO-AUTHORS
Innate immunityPharmaceutical delivery technologiesMedical molecular engineering of nucleic acids and proteinsMedical infection agents (incl. prions)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 22, 2026
Alimatravir Oral Once Monthly in Adults With Low Likelihood of HIV Exposure: A Randomized, Double-Blind, Placebo-Controlled Study.

|Apr 15, 2026
Parallel-Competitive Absorption-Presystemic Metabolism Model for Subcutaneous Bioavailability Prediction of Monoclonal Antibodies.

|Mar 14, 2026
Antiretroviral Activity, Pharmacokinetics, and Safety of MK-8527, an Oral Nucleoside Reverse Transcriptase Translocation Inhibitor, in Adults With HIV-1 Who Had Not Previously Taken Antiretroviral Agents: Results From 2 Open-Label, Phase 1 Studies.

Russ P Carstens, Yash Kapoor, Ryan C Vargo

|Dec 16, 2025
Weekly Oral Prophylaxis With MK-8527 Protects Rhesus Macaques From Intrarectal Challenge With Simian-Human Immunodeficiency Virus.

Tracy L Diamond, Yash Kapoor, Fangbiao Li

|Sep 15, 2025
Safety and Pharmacokinetics of MK-8527 in Adults Without HIV.

Gillian Gillespie, Russ P Carstens, Xiaowei Zang

|Sep 03, 2024
Predicting Human Subcutaneous Bioavailability of Therapeutic Monoclonal Antibodies from Systemic Clearance and Volume of Distribution.

Mikolaj Milewski, Mikhail Murashov, Yash Kapoor

Pageof 2

Frequent Collaborators

2 joint publications

Mikolaj Milewski

2 joint publications

Russ P Carstens

2 joint publications

Xiaowei Zang

1 joint publications

Gillian Gillespie